Bjoern Moosmann

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Tandem Mass Spectrometry

Silver Nanoparticles

Top Venues

Analytical chemistry

Drug testing and analysis

This page only lists publications with an associated author ORCID identifier.

Publications

Maja Bergerhoff, Bjoern Moosmann
Novel Receptor-Binding-Based Assay for the Detection of Opioids in Human Urine Samples. Analytical chemistry 95 (5) (2023)
Maja Bergerhoff, Bjoern Moosmann
Novel Receptor-Binding-Based Assay for the Detection of Opioids in Human Urine Samples. Analytical chemistry 95 (5) (2023)
Maja Bergerhoff, Bjoern Moosmann
Novel Receptor-Binding-Based Assay for the Detection of Opioids in Human Urine Samples. Analytical chemistry 95 (5) (2023)
Maja Bergerhoff, Bjoern Moosmann
Novel Receptor-Binding-Based Assay for the Detection of Opioids in Human Urine Samples. Analytical chemistry (2023)
Maja Bergerhoff, Bjoern Moosmann
Novel Receptor-Binding-Based Assay for the Detection of Opioids in Human Urine Samples. Analytical chemistry 95 (5) (2023)
Joana Erdmann, Bjoern Moosmann
Cross reactivity of the CEDIA and HEIA benzodiazepine kits for 29 designer benzodiazepines and tofisopam. Drug testing and analysis 13 (9) (2021)
Bjoern Moosmann, Philippe Bisel, Folker Westphal, Maurice Wilde, Jürgen Kempf, Verena Angerer, Volker Auwärter
Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864). Drug testing and analysis 11 (3) (2019)
Lukas Mogler, Florian Franz, Maurice Wilde, Laura M Huppertz, Sebastian Halter, Verena Angerer, Bjoern Moosmann, Volker Auwärter
Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples. Drug testing and analysis 10 (9) (2018)